Instituto De Investigacion Marques De Valdecilla (IDIVAL)

Santander, Cantabria 39008

0 studies enrolling now · 2 studies all time

What they study most

Obesity, Overweight, Overweight With One Weight Related Comorbidity, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity — Running, not enrolling